BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1525757)

  • 21. Carcinoembryonic antigen measurements in the management of esophageal cancer: an indicator of subclinical recurrence.
    Clark GW; Ireland AP; Hagen JA; Collard JM; Peters JH; DeMeester TR
    Am J Surg; 1995 Dec; 170(6):597-600; discussion 600-1. PubMed ID: 7492008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized "CEAwatch" trial.
    Verberne CJ; Zhan Z; van den Heuvel E; Grossmann I; Doornbos PM; Havenga K; Manusama E; Klaase J; van der Mijle HC; Lamme B; Bosscha K; Baas P; van Ooijen B; Nieuwenhuijzen G; Marinelli A; van der Zaag E; Wasowicz D; de Bock GH; Wiggers T
    Eur J Surg Oncol; 2015 Sep; 41(9):1188-96. PubMed ID: 26184850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of carcinoembryonic antigen and liver function tests in the detection of recurrent colorectal carcinoma.
    Rocklin MS; Senagore AJ; Talbott TM
    Dis Colon Rectum; 1991 Sep; 34(9):794-7. PubMed ID: 1914746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma.
    Fernandes LC; Kim SB; Matos D
    World J Gastroenterol; 2005 Feb; 11(5):645-8. PubMed ID: 15655814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lead time of carcinoembryonic antigen elevation in the postoperative follow-up of colorectal cancer did not affect the survival rate after recurrence.
    Chen CH; Hsieh MC; Lai CC; Yeh CY; Chen JS; Hsieh PS; Chiang JM; Tsai WS; Tang R; Changchien CR; Wang JY
    Int J Colorectal Dis; 2010 May; 25(5):567-71. PubMed ID: 20162425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels.
    Liu FY; Chen JS; Changchien CR; Yeh CY; Liu SH; Ho KC; Yen TC
    Dis Colon Rectum; 2005 Oct; 48(10):1900-12. PubMed ID: 15991059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer.
    Litvak A; Cercek A; Segal N; Reidy-Lagunes D; Stadler ZK; Yaeger RD; Kemeny NE; Weiser MR; Pessin MS; Saltz L
    J Natl Compr Canc Netw; 2014 Jun; 12(6):907-13. PubMed ID: 24925201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
    Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer.
    Park JW; Chang HJ; Kim BC; Yeo HY; Kim DY
    Colorectal Dis; 2013 Sep; 15(9):e503-11. PubMed ID: 23711333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biliary carcinoembryonic antigen levels can predict metachronous liver metastasis of colorectal cancer.
    Ishida H; Yoshinaga K; Gonda T; Ando M; Hojo I; Fukunari H; Iwama T; Mishima Y
    Anticancer Res; 2000; 20(1B):523-6. PubMed ID: 10769718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients.
    Choi JS; Min JS
    Yonsei Med J; 1997 Feb; 38(1):1-7. PubMed ID: 9100477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients.
    Sisik A; Kaya M; Bas G; Basak F; Alimoglu O
    Asian Pac J Cancer Prev; 2013; 14(7):4289-94. PubMed ID: 23991991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor marker analyses in patients with brain metastases: patterns of practice and implications for survival prediction research.
    Nieder C; Dalhaug A; Haukland E; Mannsåker B; Pawinski A
    Tumour Biol; 2015 Aug; 36(8):6471-6. PubMed ID: 25801247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic value of biochemical tumor markers in serum of patients with cancer of the ovary].
    Kizawa I; Kikuchi Y; Kato K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):251-8. PubMed ID: 6833810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery.
    Okamura R; Hasegawa S; Hida K; Hoshino N; Kawada K; Sugihara K; Sakai Y;
    Int J Clin Oncol; 2017 Feb; 22(1):96-101. PubMed ID: 27503134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of postoperative CEA for surveillance of recurrence after resection of primary colorectal cancer.
    Bhatti I; Patel M; Dennison AR; Thomas MW; Garcea G
    Int J Surg; 2015 Apr; 16(Pt A):123-128. PubMed ID: 25771102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
    Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoembryonic antigen testing after curative liver resection for synchronous liver metastasis of colorectal cancer: a Japanese multicenter analysis.
    Okazaki S; Baba H; Iwata N; Yamauchi S; Sugihara K
    Surg Today; 2017 Oct; 47(10):1223-1229. PubMed ID: 28439715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors].
    Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.